FACS analysis demonstrates that approximately 90% of TcdBFBD-bound cells from primary p53/BRCA1-deficient tumors were FZD7+ (S13A Fig), confirming that TcdBFBD targeted FZD7+ cells in tumor tissues. This evidence concerns the gene BRCA1 and neoplasm.